Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Abstract Incorporating pharmacogenetics into clinical practice promises to improve therapeutic outcomes by optimizing drug selection and dosage based on genetic factors affecting drug response. A key advantage of PGx-guided therapy is to decrease the likelihood of adverse events. To evaluate the cli...
Saved in:
Similar Items
-
The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea
by: Kuo-Tung Huang, et al.
Published: (2014-01-01) -
Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes
by: Jia-Jin Chen, et al.
Published: (2024-11-01) -
Extraction of degraded proteins from red and green macroalgae using ultrasonic-assisted extraction and Fenton's reagent in combination
by: Lin Ching I, et al.
Published: (2025-01-01) -
Efficacy of astragalus polysaccharides (PG2) in alleviating chemotherapy-induced fatigue in gynecologic cancer: a retrospective cohort study
by: Chia-Ching Chang, et al.
Published: (2025-07-01) -
Blood pressure targets, medication consideration and unique concerns in elderly hypertension IV: Focus on frailty, orthostatic hypotension, and resistant hypertension
by: Po-Sheng Wu, et al.
Published: (2025-07-01)